727 related articles for article (PubMed ID: 8689764)
21. [Survival prognosis in pemphigoid. A cohort analysis of 78 patients].
Bernard P; Enginger V; Venot J; Bedane C; Bonnetblanc JM
Ann Dermatol Venereol; 1995; 122(11-12):751-7. PubMed ID: 8729818
[TBL] [Abstract][Full Text] [Related]
22. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
[TBL] [Abstract][Full Text] [Related]
23. An animal model of bullous pemphigoid: what can it teach us?
Giudice GJ; Liu Z; Diaz LA
Proc Assoc Am Physicians; 1995 Jul; 107(2):237-41. PubMed ID: 8624858
[TBL] [Abstract][Full Text] [Related]
24. Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption.
Herrero-González JE; Sitaru C; Klinker E; Bröcker EB; Zillikens D
Clin Exp Dermatol; 2005 Sep; 30(5):519-22. PubMed ID: 16045683
[TBL] [Abstract][Full Text] [Related]
25. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T
Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
[TBL] [Abstract][Full Text] [Related]
26. Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid.
Liu Z; Diaz LA; Swartz SJ; Troy JL; Fairley JA; Giudice GJ
J Immunol; 1995 Dec; 155(11):5449-54. PubMed ID: 7594563
[TBL] [Abstract][Full Text] [Related]
27. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
Horváth B; Niedermeier A; Podstawa E; Müller R; Hunzelmann N; Kárpáti S; Hertl M
Exp Dermatol; 2010 Jul; 19(7):648-53. PubMed ID: 20500772
[TBL] [Abstract][Full Text] [Related]
28. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
29. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
Allen J; Shears E; Powell J; Wojnarowska F
Br J Dermatol; 2001 Mar; 144(3):540-5. PubMed ID: 11260011
[TBL] [Abstract][Full Text] [Related]
30. Development of an ELISA for the detection of autoantibodies to BP230.
Kromminga A; Sitaru C; Hagel C; Herzog S; Zillikens D
Clin Immunol; 2004 Apr; 111(1):146-52. PubMed ID: 15093564
[TBL] [Abstract][Full Text] [Related]
31. Anti-basement membrane zone antibodies in elderly patients with pruritic disorders and diabetes mellitus.
Jedlickova H; Racovska J; Niedermeier A; Feit J; Hertl M
Eur J Dermatol; 2008; 18(5):534-8. PubMed ID: 18693156
[TBL] [Abstract][Full Text] [Related]
32. Absence of anti-BP180 antibodies in mothers of infants with bullous pemphigoid.
Chiavérini C; Hamel-Teillac D; Gilbert D; Prost Y
Br J Dermatol; 2006 May; 154(5):839-43. PubMed ID: 16634883
[TBL] [Abstract][Full Text] [Related]
33. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
[TBL] [Abstract][Full Text] [Related]
34. Relationship between the in vivo localization and the immunoblotting pattern of anti-basement membrane zone antibodies in patients with bullous pemphigoid.
Joly P; Gilbert D; Thomine E; Delpech A; Courville P; Young P; Le Corvaisier C; Lauret P; Tron F
Arch Dermatol; 1997 Jun; 133(6):719-24. PubMed ID: 9197825
[TBL] [Abstract][Full Text] [Related]
35. Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects.
Wieland CN; Comfere NI; Gibson LE; Weaver AL; Krause PK; Murray JA
Arch Dermatol; 2010 Jan; 146(1):21-5. PubMed ID: 20083688
[TBL] [Abstract][Full Text] [Related]
36. The predominance of IgG4 in prodromal bullous pemphigoid.
Lamb PM; Patton T; Deng JS
Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
[TBL] [Abstract][Full Text] [Related]
37. Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen.
Murakami H; Amagai M; Higashiyama M; Hashimoto K; Chorzelski TP; Bhogal BS; Jenkins RE; Black MM; Zillikens D; Nishikawa T; Hashimoto T
J Dermatol Sci; 1996 Nov; 13(2):112-7. PubMed ID: 8953410
[TBL] [Abstract][Full Text] [Related]
38. Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis.
Yayli S; Pelivani N; Beltraminelli H; Wirthmüller U; Beleznay Z; Horn M; Borradori L
Br J Dermatol; 2011 Nov; 165(5):1133-7. PubMed ID: 21711326
[TBL] [Abstract][Full Text] [Related]
39. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid.
Yoshida M; Hamada T; Amagai M; Hashimoto K; Uehara R; Yamaguchi K; Imamura K; Okamoto E; Yasumoto S; Hashimoto T
J Dermatol Sci; 2006 Jan; 41(1):21-30. PubMed ID: 16364599
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.
Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA
Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
